Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

133.32 -41.06 (-23.55%)

Official Closing Price Updated: 4:15 PM EDT, Aug 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

October 30, 2025

Via Benzinga

Is Moderna Inc Gaining or Losing Market Support? ↗

October 30, 2025

Via Benzinga

1 S&P 500 Stock to Research Further and 2 We Find Risky

October 30, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 28, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.

Via Chartmill

Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers

October 27, 2025

As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence

October 23, 2025

New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares...

Via MarketMinute

Topics Earnings Supply Chain

Moderna Named a Top Employer by Science for Eleventh Consecutive Year

October 23, 2025

Via ACCESS Newswire

Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection ↗

October 23, 2025

Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven and financial guidance.

Via Benzinga

Moderna Topples, Threatening Its 50-Day Line, After A Key Vaccine Bites The Dust ↗

October 23, 2025

The company is scrapping its study in congenital CMV after the vaccine proved just 6% to 23% effective.

Via Investor's Business Daily

Wondering what's happening in today's S&P500 pre-market session? ↗

October 23, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

Via Chartmill

Moderna to Host Investor Event - Analyst Day

October 23, 2025

Via ACCESS Newswire

Moderna Stock Slides After-Hours On CMV Vaccine Failure In Phase 3 Trial — Retail Traders Warn Of ‘Endless’ Cash Burn ↗

October 23, 2025

The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified.

Via Stocktwits

What's going on in today's after hours session: S&P500 movers ↗

October 22, 2025

Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Global Economic Freedom in Retreat: A Four-Year Decline Signals Looming Market Shifts

October 22, 2025

Washington D.C., October 22, 2025 – The world stands at a critical juncture as the 2025 Economic Freedom of the World index, prominently released by the Fraser Institute in collaboration with the Cato...

Via MarketMinute

Topics Bonds Brexit Economy

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

October 22, 2025

Via ACCESS Newswire

Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why. ↗

October 22, 2025

The biotech's innovative qualities will come in handy.

Via The Motley Fool

Should You Buy Moderna Right Now? ↗

October 22, 2025

Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough.

Via The Motley Fool

Topics Bonds

Wellgistics And DataVault Team Up To Transform Prescription Tracking ↗

October 22, 2025

DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.

Via Benzinga

Topics Artificial Intelligence

These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall ↗

October 21, 2025

Don't try to catch a falling surgical knife.

Via The Motley Fool

Topics Government

Dow Jumps More Than 500 Points Ahead Of Earnings: Investor Fear Eases, Greed Index Remains In 'Fear' Zone ↗

October 21, 2025

U.S. stocks rise on Monday, with the Dow up 500+ points. Moderna and Cleveland-Cliffs report gains. Most S&P sectors close higher, with Fear & Greed Index at 30.3.

Via Benzinga

Topics Stocks

Small Caps Rally As Credit Fears Ease, Gold Rebounds To $4,350: What's Moving Markets Monday? ↗

October 20, 2025

Via Benzinga

What's going on in today's session: S&P500 movers ↗

October 20, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Via Chartmill

Stay informed with the top movers within the S&P500 index on Monday. ↗

October 20, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus ↗

October 20, 2025

U.S. stock futures rose on Monday following Friday’s advances. Futures of major benchmark indices were higher.

Via Benzinga

Topics Stocks

2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm

October 20, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts

October 19, 2025

The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

October 19, 2025

Via ACCESS Newswire

Healthcare’s AI Revolution: Generative Intelligence Delivers Real Returns as Agentic Systems Drive Measurable Outcomes

October 17, 2025

The healthcare industry is experiencing a profound transformation, propelled by the accelerating adoption of artificial intelligence. While AI's potential has long been discussed, recent advancements...

Via TokenRing AI

Topics Artificial Intelligence Economy

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 17, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

October 16, 2025

Via ACCESS Newswire

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Moderna, Inc. - Common Stock (NQ:MRNA)

All News about Moderna, Inc. - Common Stock